Quick Answer
ClearPoint Neuro, Inc. reported Cash And Cash Equivalents At Carrying Value of $45.92 million for the year ending 2025.
- ClearPoint Neuro, Inc. showed an increase of +128.4% in Cash And Cash Equivalents At Carrying Value from 2024 to 2025.
- This data is from ClearPoint Neuro, Inc.'s annual report (Form 10-K), filed with the SEC on March 17, 2026.
- XBRL data for this metric is available from 2009 to 2025 (17 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 17 years of available data (2009 to 2025), ClearPoint Neuro, Inc.'s Cash And Cash Equivalents At Carrying Value has grown by 1,687.5%.
- Historical annual values: Fiscal year 2025: $45.92 million | Fiscal year 2024: $20.10 million | Fiscal year 2023: $23.14 million | Fiscal year 2022: $27.62 million | Fiscal year 2021: $54.11 million | Fiscal year 2020: $20.10 million | Fiscal year 2019: $5.70 million | Fiscal year 2018: $3.10 million | Fiscal year 2017: $9.29 million | Fiscal year 2016: $3.32 million | Fiscal year 2015: $5.41 million | Fiscal year 2014: $9.24 million | Fiscal year 2013: $3.52 million | Fiscal year 2012: $1.62 million | Fiscal year 2011: $145.5 thousand | Fiscal year 2010: $1.58 million | Fiscal year 2009: $2.57 million.
- Data sourced from SEC EDGAR public filings as of June 23, 2026.
Last verified: